Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Profit After Tax (2022 - 2025)

Historic Profit After Tax for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$6.0 million.

  • PAVmed's Profit After Tax changed N/A to -$6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $39.8 million for FY2024, which is 15020.12% up from last year.
  • As of Q3 2025, PAVmed's Profit After Tax stood at -$6.0 million.
  • PAVmed's Profit After Tax's 5-year high stood at $19.0 million during Q1 2025, with a 5-year trough of -$29.9 million in Q3 2022.
  • Over the past 4 years, PAVmed's median Profit After Tax value was -$18.2 million (recorded in 2023), while the average stood at -$15.3 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first tumbled by 1314.62% in 2023, then surged by 20246.33% in 2025.
  • PAVmed's Profit After Tax (Quarter) stood at -$24.6 million in 2022, then rose by 29.16% to -$17.4 million in 2023, then surged by 108.22% to $1.4 million in 2024, then crashed by 520.06% to -$6.0 million in 2025.
  • Its last three reported values are -$6.0 million in Q3 2025, -$12.3 million for Q2 2025, and $19.0 million during Q1 2025.